Continuum Advisory’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.1K Buy
+2,359
New +$56.3K ﹤0.01% 773
2025
Q2
Sell
-1,280
Closed -$30.4K 932
2025
Q1
$30.4K Hold
1,280
﹤0.01% 781
2024
Q4
$30K Buy
1,280
+939
+275% +$22.3K ﹤0.01% 765
2024
Q3
$8.07K Hold
341
﹤0.01% 1056
2024
Q2
$7.95K Hold
341
﹤0.01% 1004
2024
Q1
$7.95K Buy
+341
New +$8.02K ﹤0.01% 998

Other funds holding IBD

Continuum Advisory's IBD Position: Q2 2026 in Review

Continuum Advisory opened a new position in Inspire Corporate Bond ETF (IBD) in Q2 2026: 2,359 shares worth $56.1K. The stake represents ﹤0.01% of the portfolio and ranks #773 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in IBD as recently as Q1 2025.

Continuum Advisory first reported a position in IBD in Q1 2024 and has held it in 6 quarters since. 110 funds tracked by Wall St. Rank hold IBD as of Q2 2026.

  • Continuum Advisory held 2,359 shares of Inspire Corporate Bond ETF worth $56.1K as of Q2 2026.
  • Inspire Corporate Bond ETF was a new Continuum Advisory position in Q2 2026.
  • Inspire Corporate Bond ETF made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #773 holding.
  • Continuum Advisory first reported a position in Inspire Corporate Bond ETF in Q1 2024 and has held it in 6 quarters since.
  • 110 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.